BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37730840)

  • 1. Long non-coding RNA SNHG8 drives stress granule formation in tauopathies.
    Bhagat R; Minaya MA; Renganathan A; Mehra M; Marsh J; Martinez R; Eteleeb AM; Nana AL; Spina S; Seeley WW; Grinberg LT; Karch CM
    Mol Psychiatry; 2023 Nov; 28(11):4889-4901. PubMed ID: 37730840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA
    Bhagat R; Minaya MA; Renganathan A; Mehra M; Marsh J; Martinez R; Nana AL; Spina S; Seeley WW; Grinberg LT; Karch CM
    medRxiv; 2023 Mar; ():. PubMed ID: 36909621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
    Jiang S; Wen N; Li Z; Dube U; Del Aguila J; Budde J; Martinez R; Hsu S; Fernandez MV; Cairns NJ; ; ; Harari O; Cruchaga C; Karch CM
    Transl Psychiatry; 2018 Dec; 8(1):265. PubMed ID: 30546007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
    García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
    Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration.
    Simone R; Javad F; Emmett W; Wilkins OG; Almeida FL; Barahona-Torres N; Zareba-Paslawska J; Ehteramyan M; Zuccotti P; Modelska A; Siva K; Virdi GS; Mitchell JS; Harley J; Kay VA; Hondhamuni G; Trabzuni D; Ryten M; Wray S; Preza E; Kia DA; Pittman A; Ferrari R; Manzoni C; Lees A; Hardy JA; Denti MA; Quattrone A; Patani R; Svenningsson P; Warner TT; Plagnol V; Ule J; de Silva R
    Nature; 2021 Jun; 594(7861):117-123. PubMed ID: 34012113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved gene signatures shared among
    Minaya MA; Mahali S; Iyer AK; Eteleeb AM; Martinez R; Huang G; Budde J; Temple S; Nana AL; Seeley WW; Spina S; Grinberg LT; Harari O; Karch CM
    Front Mol Biosci; 2023; 10():1051494. PubMed ID: 36845551
    [No Abstract]   [Full Text] [Related]  

  • 9. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
    Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
    Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
    Strang KH; Golde TE; Giasson BI
    Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau Isoforms: Gaining Insight into
    Corsi A; Bombieri C; Valenti MT; Romanelli MG
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
    Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
    Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau alternative splicing in familial and sporadic tauopathies.
    Niblock M; Gallo JM
    Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.
    Karch CM; Kao AW; Karydas A; Onanuga K; Martinez R; Argouarch A; Wang C; Huang C; Sohn PD; Bowles KR; Spina S; Silva MC; Marsh JA; Hsu S; Pugh DA; Ghoshal N; Norton J; Huang Y; Lee SE; Seeley WW; Theofilas P; Grinberg LT; Moreno F; McIlroy K; Boeve BF; Cairns NJ; Crary JF; Haggarty SJ; Ichida JK; Kosik KS; Miller BL; Gan L; Goate AM; Temple S;
    Stem Cell Reports; 2019 Nov; 13(5):939-955. PubMed ID: 31631020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology.
    Sato C; Mallipeddi N; Ghoshal N; Wright BA; Day GS; Davis AA; Kim AH; Zipfel GJ; Bateman RJ; Gabelle A; Barthélemy NR
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1817-1830. PubMed ID: 34342183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model.
    Houben S; Leroy K; Ando K; Yilmaz Z; Widomski C; Buée L; Brion JP
    Neurobiol Dis; 2019 Jul; 127():131-141. PubMed ID: 30818066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.